• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

IL-1β 通过 PD-L1 增强人胎盘间充质基质细胞调节 Th1/Th2 和 Th1/CD4IL-10 T 细胞平衡的能力,并调节其黏附、增殖和迁移。

IL-1β enhances human placenta-derived mesenchymal stromal cells ability to mediate Th1/Th2 and Th1/CD4IL-10 T cell balance and regulates its adhesion, proliferation and migration via PD-L1.

机构信息

Department of Immunology, Binzhou Medical University, Yantai, Shandong Province 264003, People's Republic of China.

Department of Anatomy, Binzhou Medical University, Yantai, Shandong Province 264003, People's Republic of China.

出版信息

Cell Immunol. 2020 Jun;352:104113. doi: 10.1016/j.cellimm.2020.104113. Epub 2020 Apr 13.

DOI:10.1016/j.cellimm.2020.104113
PMID:32331794
Abstract

Human placenta-derived mesenchymal stromal cells (hPMSCs) are promising candidates for the treatment of graft-versus-host disease (GVHD), which is associated with high IL-1β levels. In this study, the effects of IL-1β and hPMSCs on each other were investigated by analyzing the proportion of Th1, Th2 and CD4IL-10 T cells and PD-L1 expression, as well as the adhesion, migration, and proliferation of hPMSCs. The results showed that hPMSCs decreased IL-1β levels and downregulated Th1/Th2 and Th1/CD4IL-10 T cells ratios in the GVHD model. The in vitro results revealed that IL-1β strengthened the hPMSCs capacity to reduce the Th1/Th2 and Th1/CD4IL-10 T cell ratios, inhibited the adhesion and proliferation of hPMSCs and increased PD-L1 expression on hPMSCs via the JAK and NF-κB pathways. Overall, these findings suggested that hPMSCs alleviate GVHD by decreasing IL-1β level and maintaining the balance among different T cell subsets. IL-1β enhanced the ability of hPMSCs to balance different T cell subsets and inhibited hPMSCs adhesion and proliferation by regulating PD-L1 expression via the JAK and NF-κB pathways.

摘要

人胎盘间充质基质细胞(hPMSCs)是治疗移植物抗宿主病(GVHD)的有前途的候选物,GVHD 与高水平的 IL-1β 相关。在这项研究中,通过分析 Th1、Th2 和 CD4IL-10 T 细胞的比例以及 PD-L1 表达,以及 hPMSCs 的黏附、迁移和增殖,研究了 IL-1β 和 hPMSCs 之间的相互作用。结果表明,hPMSCs 降低了 GVHD 模型中的 IL-1β 水平,并下调了 Th1/Th2 和 Th1/CD4IL-10 T 细胞的比例。体外结果表明,IL-1β 通过 JAK 和 NF-κB 通路增强了 hPMSCs 降低 Th1/Th2 和 Th1/CD4IL-10 T 细胞比例的能力,抑制了 hPMSCs 的黏附和增殖,并增加了 hPMSCs 上的 PD-L1 表达。总的来说,这些发现表明,hPMSCs 通过降低 IL-1β 水平并维持不同 T 细胞亚群之间的平衡来缓解 GVHD。IL-1β 通过调节 PD-L1 表达,通过 JAK 和 NF-κB 通路增强了 hPMSCs 平衡不同 T 细胞亚群的能力,并抑制了 hPMSCs 的黏附和增殖。

相似文献

1
IL-1β enhances human placenta-derived mesenchymal stromal cells ability to mediate Th1/Th2 and Th1/CD4IL-10 T cell balance and regulates its adhesion, proliferation and migration via PD-L1.IL-1β 通过 PD-L1 增强人胎盘间充质基质细胞调节 Th1/Th2 和 Th1/CD4IL-10 T 细胞平衡的能力,并调节其黏附、增殖和迁移。
Cell Immunol. 2020 Jun;352:104113. doi: 10.1016/j.cellimm.2020.104113. Epub 2020 Apr 13.
2
IL-27 regulates the adherence, proliferation, and migration of MSCs and enhances their regulatory effects on Th1 and Th2 subset generations.白细胞介素-27调节间充质干细胞的黏附、增殖和迁移,并增强其对Th1和Th2亚群生成的调节作用。
Immunol Res. 2017 Aug;65(4):903-912. doi: 10.1007/s12026-017-8929-8.
3
IL-27 Promotes Human Placenta-Derived Mesenchymal Stromal Cell Ability To Induce the Generation of CD4IL-10IFN-γ T Cells via the JAK/STAT Pathway in the Treatment of Experimental Graft-versus-Host Disease.IL-27 通过 JAK/STAT 通路促进人胎盘来源间充质干细胞诱导 CD4IL-10IFN-γ T 细胞生成,用于治疗实验性移植物抗宿主病。
J Immunol. 2019 Feb 15;202(4):1124-1136. doi: 10.4049/jimmunol.1800963. Epub 2019 Jan 16.
4
hPMSCs inhibit the expression of PD-1 in CD4IL-10 T cells and mitigate liver damage in a GVHD mouse model by regulating the crosstalk between Nrf2 and NF-κB signaling pathway.hPMSCs 通过调控 Nrf2 和 NF-κB 信号通路的串扰抑制 GVHD 小鼠模型中 CD4IL-10T 细胞 PD-1 的表达,减轻肝损伤。
Stem Cell Res Ther. 2021 Jun 29;12(1):368. doi: 10.1186/s13287-021-02407-5.
5
Interferon-γ and tumor necrosis factor-α promote the ability of human placenta-derived mesenchymal stromal cells to express programmed death ligand-2 and induce the differentiation of CD4(+)interleukin-10(+) and CD8(+)interleukin-10(+)Treg subsets.干扰素-γ和肿瘤坏死因子-α可促进人胎盘来源的间充质基质细胞表达程序性死亡配体-2的能力,并诱导CD4(+)白细胞介素-10(+)和CD8(+)白细胞介素-10(+)调节性T细胞亚群的分化。
Cytotherapy. 2015 Nov;17(11):1560-71. doi: 10.1016/j.jcyt.2015.07.018.
6
Human placental mesenchymal stromal cells modulate IFN-γ and IL-10 secretion by CD4T cells via CD73, and alleviate intestinal damage in mice with graft-versus-host disease.人胎盘间充质基质细胞通过 CD73 调节 CD4T 细胞 IFN-γ 和 IL-10 的分泌,并减轻移植物抗宿主病小鼠的肠道损伤。
Int Immunopharmacol. 2023 Nov;124(Pt A):110767. doi: 10.1016/j.intimp.2023.110767. Epub 2023 Aug 30.
7
Human placental mesenchymal stromal cells promote the formation of CD8CD122PD-1Tregs via CD73/Foxo1 to alleviate liver injury in graft-versus-host disease mice.人胎盘间充质基质细胞通过 CD73/Foxo1 促进 CD8CD122PD-1Tregs 的形成,从而减轻移植物抗宿主病小鼠的肝损伤。
Int Immunopharmacol. 2024 Sep 10;138:112554. doi: 10.1016/j.intimp.2024.112554. Epub 2024 Jul 4.
8
Human placenta-derived mesenchymal stem cells ameliorate GVHD by modulating Th17/Tr1 balance via expression of PD-L2.人胎盘间充质干细胞通过表达 PD-L2 调节 Th17/Tr1 平衡改善移植物抗宿主病。
Life Sci. 2018 Dec 1;214:98-105. doi: 10.1016/j.lfs.2018.10.061. Epub 2018 Oct 27.
9
[IFN-γ up-regulates PD-L1 expression in human placenta mesenchymal stem cells and enhances cell ability to induce the differentiation of IL-10+ T cells from cord blood- and peripheral blood-derived T cells].[干扰素-γ上调人胎盘间充质干细胞中PD-L1的表达并增强其诱导脐带血和外周血来源的T细胞分化为IL-10⁺ T细胞的能力]
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2016 Feb;32(2):191-5.
10
Bone marrow-derived mesenchymal stem cells promote cell proliferation of multiple myeloma through inhibiting T cell immune responses via PD-1/PD-L1 pathway.骨髓间充质干细胞通过 PD-1/PD-L1 通路抑制 T 细胞免疫反应促进多发性骨髓瘤细胞增殖。
Cell Cycle. 2018;17(7):858-867. doi: 10.1080/15384101.2018.1442624. Epub 2018 May 21.

引用本文的文献

1
Mesenchymal stem cell therapy in eosinophilic granulomatosis with polyangiitis-related lower limb gangrene: a case report.间充质干细胞治疗嗜酸性肉芽肿伴多血管炎相关下肢坏疽:病例报告。
Stem Cell Res Ther. 2024 Sep 16;15(1):307. doi: 10.1186/s13287-024-03924-9.
2
The expression mechanism of programmed cell death 1 ligand 1 and its role in immunomodulatory ability of mesenchymal stem cells.程序性细胞死亡蛋白1配体1的表达机制及其在间充质干细胞免疫调节能力中的作用。
Chin J Traumatol. 2024 Jan;27(1):1-10. doi: 10.1016/j.cjtee.2023.11.003. Epub 2023 Nov 23.
3
hPMSCs Regulate the Level of TNF-α and IL-10 in Th1 Cells and Improve Hepatic Injury in a GVHD Mouse Model via CD73/ADO/Fyn/Nrf2 Axis.
hPMSCs 通过 CD73/ADO/Fyn/Nrf2 轴调节 Th1 细胞中 TNF-α 和 IL-10 的水平,并改善 GVHD 小鼠模型中的肝损伤。
Inflammation. 2024 Feb;47(1):244-263. doi: 10.1007/s10753-023-01907-1. Epub 2023 Oct 13.
4
The Influence of Intervertebral Disc Microenvironment on the Biological Behavior of Engrafted Mesenchymal Stem Cells.椎间盘微环境对植入间充质干细胞生物学行为的影响
Stem Cells Int. 2022 Nov 7;2022:8671482. doi: 10.1155/2022/8671482. eCollection 2022.
5
Plumping up a Cushion of Human Biowaste in Regenerative Medicine: Novel Insights into a State-of-the-Art Reserve Arsenal.在再生医学中填充人体生物废物的“软垫”:一种最先进储备武器的新见解。
Stem Cell Rev Rep. 2022 Dec;18(8):2709-2739. doi: 10.1007/s12015-022-10383-3. Epub 2022 May 3.
6
hPMSCs inhibit the expression of PD-1 in CD4IL-10 T cells and mitigate liver damage in a GVHD mouse model by regulating the crosstalk between Nrf2 and NF-κB signaling pathway.hPMSCs 通过调控 Nrf2 和 NF-κB 信号通路的串扰抑制 GVHD 小鼠模型中 CD4IL-10T 细胞 PD-1 的表达,减轻肝损伤。
Stem Cell Res Ther. 2021 Jun 29;12(1):368. doi: 10.1186/s13287-021-02407-5.
7
Advances in mesenchymal stem cell therapy for immune and inflammatory diseases: Use of cell-free products and human pluripotent stem cell-derived mesenchymal stem cells.间充质干细胞治疗免疫和炎症性疾病的进展:无细胞产品和人多能干细胞衍生的间充质干细胞的应用。
Stem Cells Transl Med. 2021 Sep;10(9):1288-1303. doi: 10.1002/sctm.21-0021. Epub 2021 May 19.
8
WJMSC-derived small extracellular vesicle enhance T cell suppression through PD-L1.WJMSC 来源的小细胞外囊泡通过 PD-L1 增强 T 细胞抑制。
J Extracell Vesicles. 2021 Feb;10(4):e12067. doi: 10.1002/jev2.12067. Epub 2021 Feb 8.
9
Understanding Inflammasomes and PD-1/PD-L1 Crosstalk to Improve Cancer Treatment Efficiency.了解炎性小体与PD-1/PD-L1的相互作用以提高癌症治疗效率。
Cancers (Basel). 2020 Nov 27;12(12):3550. doi: 10.3390/cancers12123550.